APA (7th ed.) Citation

Jr, G. L., EC, M., 3rd, A. T., BW, B., JW, H., & J, S. (2010). Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report-Part II. Value in Health, 13(1), 8. https://doi.org/10.1111/j.1524-4733.2009.00660.x

Chicago Style (17th ed.) Citation

Jr, Garrison LP, Mansley EC, Abbott TA 3rd, Bresnahan BW, Hay JW, and Smeeding J. "Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report-Part II." Value in Health 13, no. 1 (2010): 8. https://doi.org/10.1111/j.1524-4733.2009.00660.x.

MLA (9th ed.) Citation

Jr, Garrison LP, et al. "Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report-Part II." Value in Health, vol. 13, no. 1, 2010, p. 8, https://doi.org/10.1111/j.1524-4733.2009.00660.x.